Related Experiment Video

Updated: Jun 13, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Genome-wide hypomethylation in cancer may be a passive consequence of transformation

Laurence Wild1, James M Flanagan

  • 1UCL Cancer Institute, London, UK.

Biochimica Et Biophysica Acta
|April 20, 2010
PubMed

Insights

Genome-wide hypomethylation in cancer remains unclear, with ongoing debate about its role as a cause or effect. Understanding this epigenetic alteration is crucial for cancer therapy development.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Genomics

Background:

  • Epigenetics involves stable, reversible genome alterations affecting gene expression, primarily DNA methylation and histone modifications.
  • While promoter hypermethylation in cancer is well-studied, the mechanism of genome-wide hypomethylation, an early epigenetic observation in cancer, remains elusive.
  • Hypomethylation's role in carcinogenesis is debated: is it an early driver or a passive consequence?

Purpose of the Study:

  • To review the timing and potential causes of genomic hypomethylation during carcinogenesis.
  • To propose future research directions for elucidating the mechanisms of hypomethylation in cancer.
  • To highlight the clinical relevance of understanding hypomethylation, especially with DNA methyltransferase inhibitors in cancer therapy.

Main Methods:

  • Literature review focusing on epigenetic mechanisms in cancer.
  • Analysis of current evidence regarding genome-wide hypomethylation.
  • Discussion of recent discoveries in gene-body methylation and DNA demethylation.

Main Results:

  • The precise mechanism and significance of genome-wide hypomethylation in cancer are not yet fully understood.
  • Evidence is divided on whether hypomethylation initiates or accompanies cancer development.
  • Recent findings on gene-body methylation and demethylation pathways offer new insights.

Conclusions:

  • Further research is needed to clarify the role and mechanisms of genome-wide hypomethylation in cancer.
  • Understanding hypomethylation is critical for advancing epigenetic cancer therapies.
  • Elucidating hypomethylation mechanisms is a key frontier in cancer epigenetics.

More Related Videos

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...